Does MEROPENEM Cause Bronchopulmonary aspergillosis? 174 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 174 reports of Bronchopulmonary aspergillosis have been filed in association with MEROPENEM (Meropenem). This represents 1.3% of all adverse event reports for MEROPENEM.
174
Reports of Bronchopulmonary aspergillosis with MEROPENEM
1.3%
of all MEROPENEM reports
111
Deaths
108
Hospitalizations
How Dangerous Is Bronchopulmonary aspergillosis From MEROPENEM?
Of the 174 reports, 111 (63.8%) resulted in death, 108 (62.1%) required hospitalization, and 21 (12.1%) were considered life-threatening.
Is Bronchopulmonary aspergillosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEROPENEM. However, 174 reports have been filed with the FAERS database.
What Other Side Effects Does MEROPENEM Cause?
Drug ineffective (2,802)
Off label use (1,572)
Condition aggravated (706)
Pyrexia (669)
Multiple organ dysfunction syndrome (655)
Drug reaction with eosinophilia and systemic symptoms (626)
Septic shock (613)
Drug resistance (539)
Acute kidney injury (522)
Rash (437)
What Other Drugs Cause Bronchopulmonary aspergillosis?
TACROLIMUS (968)
PREDNISONE (967)
DEXAMETHASONE (854)
CYCLOPHOSPHAMIDE (824)
METHYLPREDNISOLONE (794)
PREDNISOLONE (704)
MYCOPHENOLATE MOFETIL (702)
RITUXIMAB (606)
CYCLOSPORINE (583)
METHOTREXATE (553)
Which MEROPENEM Alternatives Have Lower Bronchopulmonary aspergillosis Risk?
MEROPENEM vs MEROPENEM ANHYDROUS
MEROPENEM vs MESALAMINE
MEROPENEM vs MESNA
MEROPENEM vs METAMIZOLE
MEROPENEM vs METARAMINOL